News about "Anivive "

Anivive Bags NIAID Contract Worth Up to USD 33 Million to Progress Valley Fever Vaccine

Anivive Bags NIAID Contract Worth Up to USD 33 Million to Progress Valley Fever Vaccine

Anivive Lifesciences Inc. has announced that the National Institute of Allergy and Infectious Diseases (NIAID) has awarded Anivive a new contract worth up to USD 33 million to support the development of a vaccine against the fungus Coccidioides, which causes Valley Fever.

Anivive | 03/08/2024 | By Aishwarya 241


 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members